Javascript must be enabled to continue!
The Effect of Iron Deficiency on Cardiac Function and Structure in Heart Failure with Reduced Ejection Fraction
View through CrossRef
Over the past decade, the detrimental impact of iron deficiency in heart failure with reduced ejection fraction has become abundantly clear, showing a negative impact on functional status, quality of life, cardiac function and structure, exercise capacity and an increased risk of hospitalisation due to heart failure. Mechanistic studies have shown the impact of iron deficiency in altering mitochondrial function and negatively affecting the already altered cardiac energetics in heart failure with reduced ejection fraction. Such failing energetics form the basis of the alterations to cellular myocyte shortening, culminating in reduced systolic function and cardiac performance. The IRON-CRT trials show that ferric carboxymaltose is capable of improving cardiac structure and cardiac performance. This article discusses the effect of iron deficiency on cardiac function and structure and how it can be alleviated.
Title: The Effect of Iron Deficiency on Cardiac Function and Structure in Heart Failure with Reduced Ejection Fraction
Description:
Over the past decade, the detrimental impact of iron deficiency in heart failure with reduced ejection fraction has become abundantly clear, showing a negative impact on functional status, quality of life, cardiac function and structure, exercise capacity and an increased risk of hospitalisation due to heart failure.
Mechanistic studies have shown the impact of iron deficiency in altering mitochondrial function and negatively affecting the already altered cardiac energetics in heart failure with reduced ejection fraction.
Such failing energetics form the basis of the alterations to cellular myocyte shortening, culminating in reduced systolic function and cardiac performance.
The IRON-CRT trials show that ferric carboxymaltose is capable of improving cardiac structure and cardiac performance.
This article discusses the effect of iron deficiency on cardiac function and structure and how it can be alleviated.
Related Results
De Novo Anemia and Relationship with Vitamin C Deficiency and Zinc Deficiency in a Southern Delaware Population, a Retrospective Analysis
De Novo Anemia and Relationship with Vitamin C Deficiency and Zinc Deficiency in a Southern Delaware Population, a Retrospective Analysis
Abstract
Background:
Vitamin C is an essential dietary nutrient. It is a water soluble vitamin that exists in the body primarily in the reduced form A...
Iron stress affects the survival of Toxoplasma gondii
Iron stress affects the survival of Toxoplasma gondii
Abstract
Background
Iron possesses redox abilities and plays a crucial role in in biosynthesis, energy metabolism, and other biological processes. It represents an indispe...
Mediator kinase submodule-dependent regulation of cardiac transcription
Mediator kinase submodule-dependent regulation of cardiac transcription
<p>Pathological cardiac remodeling results from myocardial stresses including pressure and volume overload, neurohumoral activation, myocardial infarction, and hypothyroidism...
The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
Heart failure (HF) is a major health burden associated with significant morbidity and mortality. Approximately half of all HF patients have reduced ejection fraction (left ventricu...
Health-related quality of life and associated factors in heart failure with reduced ejection fraction patients at University of Gondar Hospital, Ethiopia
Health-related quality of life and associated factors in heart failure with reduced ejection fraction patients at University of Gondar Hospital, Ethiopia
IntroductionLiving with heart failure poses challenges due to its poor prognosis and impact on quality of life, making it crucial to assess how it affects patients for better patie...
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
CMR EVALUATION OF CARDIAC FUNCTION IN PATIENTS WITH METABOLIC SYNDROME IMPACT ON THE STUDY OF HYPERTENSION
CMR EVALUATION OF CARDIAC FUNCTION IN PATIENTS WITH METABOLIC SYNDROME IMPACT ON THE STUDY OF HYPERTENSION
Objectives
MRI in the evaluation of the metabolic syndrome (metabolic syndrome, MS) on left ventricular function in hypertensive patients in clinical application....

